Single Ascending Dose Study of ALA-1000

Clinical trial NCT04122755 · COMPLETED

Trial details

NCT number: NCT04122755
Sponsor: Alar Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid-use Disorder

Start date: 2019-09-16
Primary completion: 2021-05-03
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.